Estimates Revisions Unicycive Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 01:30:00 10/10/2026 am IST			5-day change	1st Jan Change
4.110 ^USD	+0.98%		-2.61%	-28.77%

01/10	Unicycive Therapeutics, Inc. Appoints Meredith Manning to its Board of Directors, Each of the Audit, Compensation, and Nominating and Corporate Governance Committees, and Chairperson of the Nominating and Corporate Governance Committee	CI
29/09	Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	UNICYCIVE THERAPEUTICS, INC.
	WUXI APPTEC CO., LTD.
	ARGENX SE
	LONZA GROUP AG
	IQVIA HOLDINGS INC.
	REVOLUTION MEDICINES, INC.
	BEONE MEDICINES AG
	CELLTRION, INC.
	WUXI BIOLOGICS (CAYMAN) INC.
	BIONTECH SE
	Average
	Weighted average by Cap.